Revenue - Schedule of Recognized Revenue Net of Payments (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Disaggregation of Revenue [Line Items]
Total revenue	$ 93,459	$ 30,262	$ 25,639
Net product revenue [Member]
Disaggregation of Revenue [Line Items]
Gross product revenue from sales to customers	77,854	30,780	27,809
Less: Clinical trial payments	(1,380)	1,123	2,717
Total revenue	$ 79,234	$ 29,657	$ 25,092